Dynamical Models of the Interactions Between Vaccination and Antibiotic Resistance

疫苗接种与抗生素耐药性相互作用的动态模型

阅读:1

Abstract

Background/Objectives: Streptococcus pneumoniae remains a major cause of invasive disease, and antimicrobial resistance is shaped by antibiotic selection and pneumococcal conjugate vaccination. A unified framework is needed to compare proposed mechanisms that maintain coexistence of antibiotic-sensitive and -resistant strains and to interpret post-vaccine resistance trajectories. Methods: We formulated a susceptible-exposed-vaccinated-infectious-recovered (SEVIR) transmission model that tracks antibiotic-sensitive and -resistant pneumococcal infections under vaccination and treatment. The basic reproduction number (R0) was derived using the next-generation matrix method and used to assess local stability of the disease-free equilibrium. Using the same core structure, we evaluated three mechanism-specific extensions: treatment diversity (heterogeneous antibiotic use across host groups), pathogen diversity (serotype/subtype heterogeneity under vaccine targeting), and treatment competition (within-host competition with treatment-induced selection). Results: Treatment diversity generated stable coexistence by creating low-treatment refugia that counterbalanced strong selection in highly treated groups, supporting resistance persistence at moderate population-average treatment. Pathogen diversity reproduced serotype-specific replacement and concentration of resistance within particular subtypes after vaccination. Treatment competition produced nonlinear responses to antibiotic intensity and transient resistance surges. Overall, each mechanism explained a distinct subset of benchmark resistance patterns, suggesting that dominant drivers depend on epidemiological context. Conclusions: Interactions between vaccination, antibiotic pressure, population heterogeneity, pathogen diversity and within-host competition can yield qualitatively different resistance dynamics. Strategies combining high vaccine uptake with targeted antibiotic stewardship are likely required to curb resistance while limiting unintended serotype replacement.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。